Arrowhead Pharmaceuticals Inc. (ARWR) is priced at $72.63 after the most recent trading session. At the very opening of the session, the stock price was $74.57 and reached a high price of $74.57, prior to closing the session it reached the value of $74.83. The stock touched a low price of $70.45.
Recently in News on December 7, 2020, Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4). Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that as an inducement to entering into employment with the Company, on December 4, 2020, the Compensation Committee of the Board of Directors approved “inducement” grants to 27 new employees under Rule 5635(c)(4) of the NASDAQ Marketplace Rules. The option grants entitle employees, in aggregate, to purchase up to 145,000 shares of common stock and receive up to 96,000 restricted stock units. The strike price of the options is set at an exercise price of $65.29, the last reported closing price of the Company’s common stock on December 4, 2020, the date of grant, except for certain shares which will be priced at the last reported closing price of the Company’s common stock on the date of hire of 11 new employees anticipated to be within two months of the date of the approval. The grants are outside the Company’s stockholder-approved equity incentive plans. The options vest and become exercisable over a period of four years. The RSUs vest annually over either one or four years. You can read further details here
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Arrowhead Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $77.11 on 01/04/21, with the lowest value was $70.45 for the same time period, recorded on 01/05/21.
Arrowhead Pharmaceuticals Inc. (ARWR) full year performance was 22.20%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arrowhead Pharmaceuticals Inc. shares are logging -16.28% during the 52-week period from high price, and 272.27% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $19.51 and $86.75.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1264436 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arrowhead Pharmaceuticals Inc. (ARWR) recorded performance in the market was -5.34%, having the revenues showcasing 54.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.53B, as it employees total of 98 workers.
Arrowhead Pharmaceuticals Inc. (ARWR) in the eye of market guru’s
During the last month, 8 analysts gave the Arrowhead Pharmaceuticals Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 56.46, with a change in the price was noted +29.82. In a similar fashion, Arrowhead Pharmaceuticals Inc. posted a movement of +69.66% for the period of last 100 days, recording 1,393,697 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARWR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Arrowhead Pharmaceuticals Inc. (ARWR): Stocks Technical analysis and Trends
Raw Stochastic average of Arrowhead Pharmaceuticals Inc. in the period of last 50 days is set at 54.71%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.96%. In the last 20 days, the company’s Stochastic %K was 48.15% and its Stochastic %D was recorded 54.30%.
If we look into the earlier routines of Arrowhead Pharmaceuticals Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -5.34%. Additionally, trading for the stock in the period of the last six months notably improved by 64.17%, alongside a boost of 22.20% for the period of the last 12 months. The shares increased approximately by -9.14% in the 7-day charts and went down by 13.52% in the period of the last 30 days. Common stock shares were driven by 54.17% during last recorded quarter.